7,428 followers
Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover fo http://t.co/bgAnwJxDb7 http://t.co/v1oC4EkLeE
Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer
Overview of attention for article published in Clinical Cancer Research, March 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (84th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Readers on
- mendeley
- 61 Mendeley